Aurobindo Pharma Ownership

Aurobindo Pharma holds a total of 580.8 Million outstanding shares. Aurobindo Pharma Limited retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Aurobindo Pharma in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Aurobindo Pharma, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. The current year's Dividends Paid is expected to grow to about 2.8 B. The current year's Net Income Applicable To Common Shares is expected to grow to about 27.1 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 649.9 M. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurobindo Pharma Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.